Alzheimer's impacts millions globally, with projections of 100 million affected by 2050 and costs of 800 billion dollars ...

Increasing the levels of a particular phospholipid in the membranes of brain cells may offer a promising new way to improve blood circulation in the brain and support healthier brain activity. A poten ...

Grief is often associated with death, says Paul Rado, 71, of La Plata County. But as he cares for his wife Jackie, 77, who ...

La Plata County resident Al Jason, 78, has spent a lifetime caring for others. After his Alzheimer’s disease diagnosis last ...

Oversold shares of Nike (NYSE: NKE) are on the run. All on news that CEO Elliott Hill bought 16,400 shares for about $1 ...

Alzheimer’s disease blood test developer Quanterix put forward new clinical data from its Simoa assay, which it described as ...

On Dec. 30, the Caddo Parish Sheriff’s Office (CPSO) asks for the public’s help in finding Kindley Thompson, 81, from Vivian, ...

FDA grants priority review to Axsome's AXS-05 for treating agitation in Alzheimer's disease with a PDUFA date of April 30, 2026.

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing Axsome Therapeutics shares rose Wednesday morning after the Food and Drug Administration gave its Alzheimer's ...

New guidelines for blood-based biomarkers, the impact of hormone replacement therapy and risks for cognitive decline with red ...

Scientists have long wondered why women are more affected by this disease than men. A research team at the University of ...

Scientists at Johns Hopkins Medicine have discovered something surprising that could lead to new treatments for Alzheimer’s ...